Northwire Canada EditionWednesday, July 15, 2026
Northwire
SGQ 0.400 +5.3% GMX 1.87 −1.6% ALM 0.310 +0.0% WCU 0.010 +0.0% NTH 0.155 −6.1% GGM 0.035 +0.0% FG 0.035 +0.0% EFR 17.86 −4.0% IVN 10.54 −2.2% MASS 0.090 +0.0% LIF 26.60 −2.2% CPAU 0.155 +0.0% PTX 0.105 −4.5% VENT 0.160 +0.0% ANK 0.275 −5.2% ODV 3.38 +0.3% SGQ 0.400 +5.3% GMX 1.87 −1.6% ALM 0.310 +0.0% WCU 0.010 +0.0% NTH 0.155 −6.1% GGM 0.035 +0.0% FG 0.035 +0.0% EFR 17.86 −4.0% IVN 10.54 −2.2% MASS 0.090 +0.0% LIF 26.60 −2.2% CPAU 0.155 +0.0% PTX 0.105 −4.5% VENT 0.160 +0.0% ANK 0.275 −5.2% ODV 3.38 +0.3%
M&A / Property

Eshbal signs LOI to acquire interest in Dare to Be

ESBL · Price

Executive Summary

  • Eshbal Functional Food Inc. has signed a binding letter of intent to acquire a 55% majority interest in Dare to Be Different Foods (D2BD), a New York-based producer of low-carb, gluten-free, and natural-ingredient products.
  • The acquisition consideration involves a combination of cash subscription for newly issued D2BD securities and the issuance of Eshbal shares to existing D2BD shareholders, with potential additional share issuances based on future revenue thresholds.
  • Concurrently, Eshbal appointed Avi Markus as Chief Commercial Officer for North America to lead the company's commercial expansion in the region.

Key Details

  • Transaction Structure: Binding Letter of Intent (LOI) effective July 3, 2025.
  • Target: Dare to Be Different Foods (D2BD), based in New York.
  • Asset Acquired: 55% interest in issued and outstanding securities of D2BD on a fully diluted basis.
  • Target Business: Specializes in low-carb, gluten-free, and natural-ingredient products made from broccoli and cauliflower (crusts, crisps, gnocchi, etc.), sold via natural grocery chains and online platforms.
  • Consideration:
    • Cash subscription by Eshbal for newly issued D2BD securities (proceeds paid to D2BD treasury).
    • Issuance of Eshbal shares to existing D2BD shareholders.
    • Potential additional Eshbal shares issuable if D2BD meets certain revenue thresholds.
  • Valuation/Price Determination: Actual cash amounts and number of Eshbal shares to be determined after due diligence; Eshbal share issuance price to be set upon execution of the definitive agreement.
  • Closing Conditions: Subject to entry into a definitive agreement, customary closing conditions, and approval from the TSX Venture Exchange.
  • Arm's Length: Transaction is arm's length; no finders' fees are payable.
  • Executive Appointment: Avi Markus appointed as Chief Commercial Officer (CCO) for North America.
  • Executive Background: Markus has over 25 years of experience in consumer-packaged goods, previously serving as SVP North America -- Retail at Else Nutrition, partner at The Matzo Project, and holding roles at Unilever Canada and Shoppers Drug Mart. He holds an MBA from Schulich School of Business.
  • Role Responsibilities: Lead commercial operations in North America, including sales, distribution, partnerships, and business development.

Notable Quotes

  • "I am so pleased to be joining this unique team of creative professionals in the field of better-for-you nutrition," said Mr. Markus. "Eshbal is already a leading international player in healthier food solutions, and I look forward to introducing its products to leading retailers and food-service accounts across the U.S. and Canada."
Read the original news release →

More from Eshbal Functional Food Inc